{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:34:04Z","timestamp":1784331244840,"version":"3.55.0"},"reference-count":46,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000948","name":"Pfizer Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Comorbid conditions are common and impact outcomes in people with rheumatoid arthritis (RA), but less data are available for psoriatic arthritis (PsA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To describe baseline demographics and prevalence of comorbidities in participants with PsA in an Australian cohort using data from the Australian Rheumatology Association Database (ARAD) and to compare the prevalence of comorbidities in ARAD participants with PsA with those with RA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>ARAD is a voluntary national registry for inflammatory arthritis. Data, including demographic details, medication use, history of comorbid medical illnesses and patient\u2010reported outcomes, all self\u2010reported, were extracted from questionnaires completed at the time of database enrolment for participants with PsA and RA. Demographic information and prevalence of comorbidities were summarised using descriptive statistics. Prevalence of comorbidities in PsA and RA were compared using logistic regression, adjusting for age, gender, disease duration, education, employment and prednisone use.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>There were 490 participants with PsA, 59.2% female, mean (standard deviation (SD)) age 50.4 (21.1) years and disease duration 16.4 (9.7) years, and 57.8% reported having two or more comorbidities. Hypertension (38.2%) and depression (35.9%) were the most common. Compared with RA, participants with PsA had greater odds of depression (adjusted OR (95% CI): 2.1 (1.7\u20132.6)), hypertension (1.7 (1.4\u20132.1)), hyperlipidaemia (2.0 (1.6\u20132.5)), diabetes (2.2 (1.6\u20133.0)) and a history of ischaemic heart disease (2.0 (1.3\u20132.9)).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High rates of comorbidity were found in ARAD participants with PsA. The prevalence of depression, cardiovascular risk factors and other comorbidities were higher in PsA than RA participants in our Australian cohort.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.14046","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T08:58:39Z","timestamp":1532595519000},"page":"1360-1368","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comorbidity in psoriatic arthritis and rheumatoid arthritis"],"prefix":"10.1111","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8142-1274","authenticated-orcid":false,"given":"Premarani","family":"Sinnathurai","sequence":"first","affiliation":[{"name":"Institute of Bone and Joint Research, Kolling Institute Northern Sydney Local Health District  Sydney New South Wales Australia"},{"name":"Department of Rheumatology Royal North Shore Hospital  St Leonards New South Wales Australia"},{"name":"Sydney Medical School University of Sydney  New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-0933","authenticated-orcid":false,"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[{"name":"Monash Department of Clinical Epidemiology Cabrini Institute  Victoria Australia"},{"name":"Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Hill","sequence":"additional","affiliation":[{"name":"The Queen Elizabeth Hospital  Adelaide South Australia Australia"},{"name":"University of Adelaide  Adelaide South Australia Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Lassere","sequence":"additional","affiliation":[{"name":"School of Public Health and Community Medicine University of New South Wales  New South Wales Australia"},{"name":"Department of Rheumatology St George Hospital  Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"March","sequence":"additional","affiliation":[{"name":"Institute of Bone and Joint Research, Kolling Institute Northern Sydney Local Health District  Sydney New South Wales Australia"},{"name":"Department of Rheumatology Royal North Shore Hospital  St Leonards New South Wales Australia"},{"name":"Sydney Medical School University of Sydney  New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032482"},{"key":"e_1_2_7_3_1","first-page":"1354","article-title":"Incidence and prevalence of psoriatic arthritis: a systematic review","volume":"35","author":"Alamanos Y","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0182-x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121500"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1692-7"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000152"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(73)90035-8"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401021"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201194"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23094"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22926"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22185"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12580"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/861481"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-015-0772-2"},{"key":"e_1_2_7_17_1","unstructured":"Australian Institute of Health and Welfare. How many Australians have diabetes?2016. Available from URL:https:\/\/www.aihw.gov.au\/reports\/diabetes\/diabetes-compendium\/contents\/how-many-australians-have-diabetes"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1787\/factbook-2015-91-en"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2017-5"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201299"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12163"},{"key":"e_1_2_7_22_1","volume-title":"Australia's Health 2016. Australia's Health Series No. 15. Cat. no. AUS 199","author":"Australian Institute of Health and Welfare","year":"2016"},{"key":"e_1_2_7_23_1","volume-title":"Skin Cancer in Australia. Cat. No. CAN 96","author":"Australian Institute of Health and Welfare","year":"2016"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12165"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2007.01431.x"},{"key":"e_1_2_7_26_1","first-page":"1401","article-title":"Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the rheumatology common toxicity criteria v.2.0","volume":"34","author":"Woodworth T","year":"2007","journal-title":"J Rheumatol"},{"key":"e_1_2_7_27_1","first-page":"2037","article-title":"Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update","volume":"32","author":"Lassere MND","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_7_28_1","first-page":"2033","article-title":"Generic patient self\u2010report and investigator report instruments of therapeutic safety and tolerability","volume":"32","author":"Lassere MND","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2670"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-32"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4049"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/941767"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2743-7"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.12.002"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.136499"},{"key":"e_1_2_7_36_1","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han C","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1089\/met.2013.0039"},{"key":"e_1_2_7_38_1","first-page":"60","article-title":"On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population\u2010based data from the Nord\u2010Trondelag Health Study","volume":"74","author":"Gulati AM","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1089\/met.2009.0124"},{"key":"e_1_2_7_40_1","unstructured":"Australian Institute of Health and Welfare. How many Australians have cardiovascular disease?2016[cited 2017 Sep 18]. Available from URL:https:\/\/www.aihw.gov.au\/reports\/heart-stroke-vascular-disease\/cardiovascular-health-compendium\/contents\/how-many-australians-have-cardiovascular-disease"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140021"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204448"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2006.tb00086.x"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-eular.3813"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10993"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2004.04.005"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a117078"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fimj.14046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.14046","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.14046","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.14046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T12:56:08Z","timestamp":1694264168000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.14046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1111\/imj.14046"],"URL":"https:\/\/doi.org\/10.1111\/imj.14046","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"2018-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-17","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}